These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 32911590)

  • 1. From intestinal dysbiosis to alcohol-associated liver disease.
    Mendes BG; Schnabl B
    Clin Mol Hepatol; 2020 Oct; 26(4):595-605. PubMed ID: 32911590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microbiome as a therapeutic target in alcohol-related liver disease.
    Sarin SK; Pande A; Schnabl B
    J Hepatol; 2019 Feb; 70(2):260-272. PubMed ID: 30658727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intestinal REG3 Lectins Protect against Alcoholic Steatohepatitis by Reducing Mucosa-Associated Microbiota and Preventing Bacterial Translocation.
    Wang L; Fouts DE; Stärkel P; Hartmann P; Chen P; Llorente C; DePew J; Moncera K; Ho SB; Brenner DA; Hooper LV; Schnabl B
    Cell Host Microbe; 2016 Feb; 19(2):227-39. PubMed ID: 26867181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacteria engineered to produce IL-22 in intestine induce expression of REG3G to reduce ethanol-induced liver disease in mice.
    Hendrikx T; Duan Y; Wang Y; Oh JH; Alexander LM; Huang W; Stärkel P; Ho SB; Gao B; Fiehn O; Emond P; Sokol H; van Pijkeren JP; Schnabl B
    Gut; 2019 Aug; 68(8):1504-1515. PubMed ID: 30448775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intestinal dysbiosis and permeability: the yin and yang in alcohol dependence and alcoholic liver disease.
    Stärkel P; Leclercq S; de Timary P; Schnabl B
    Clin Sci (Lond); 2018 Jan; 132(2):199-212. PubMed ID: 29352076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The gut-liver axis in liver disease: Pathophysiological basis for therapy.
    Albillos A; de Gottardi A; Rescigno M
    J Hepatol; 2020 Mar; 72(3):558-577. PubMed ID: 31622696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intestinal HIF-1α deletion exacerbates alcoholic liver disease by inducing intestinal dysbiosis and barrier dysfunction.
    Shao T; Zhao C; Li F; Gu Z; Liu L; Zhang L; Wang Y; He L; Liu Y; Liu Q; Chen Y; Donde H; Wang R; Jala VR; Barve S; Chen SY; Zhang X; Chen Y; McClain CJ; Feng W
    J Hepatol; 2018 Oct; 69(4):886-895. PubMed ID: 29803899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alcoholic liver disease: the gut microbiome and liver cross talk.
    Hartmann P; Seebauer CT; Schnabl B
    Alcohol Clin Exp Res; 2015 May; 39(5):763-75. PubMed ID: 25872593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review article: the gut microbiome as a therapeutic target in the pathogenesis and treatment of chronic liver disease.
    Woodhouse CA; Patel VC; Singanayagam A; Shawcross DL
    Aliment Pharmacol Ther; 2018 Jan; 47(2):192-202. PubMed ID: 29083037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enteric dysbiosis associated with a mouse model of alcoholic liver disease.
    Yan AW; Fouts DE; Brandl J; Stärkel P; Torralba M; Schott E; Tsukamoto H; Nelson KE; Brenner DA; Schnabl B
    Hepatology; 2011 Jan; 53(1):96-105. PubMed ID: 21254165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deficiency of intestinal mucin-2 ameliorates experimental alcoholic liver disease in mice.
    Hartmann P; Chen P; Wang HJ; Wang L; McCole DF; Brandl K; Stärkel P; Belzer C; Hellerbrand C; Tsukamoto H; Ho SB; Schnabl B
    Hepatology; 2013 Jul; 58(1):108-19. PubMed ID: 23408358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rice Bran Phenolic Extract Protects against Alcoholic Liver Injury in Mice by Alleviating Intestinal Microbiota Dysbiosis, Barrier Dysfunction, and Liver Inflammation Mediated by the Endotoxin-TLR4-NF-κB Pathway.
    Xiao J; Zhang R; Wu Y; Wu C; Jia X; Dong L; Liu L; Chen Y; Bai Y; Zhang M
    J Agric Food Chem; 2020 Feb; 68(5):1237-1247. PubMed ID: 31722525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Host Factors in Dysregulation of the Gut Barrier Function during Alcohol-Associated Liver Disease.
    Maccioni L; Leclercq IA; Schnabl B; Stärkel P
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Aryl Hydrocarbon Receptor (AHR) as a Potential Target for the Control of Intestinal Inflammation: Insights from an Immune and Bacteria Sensor Receptor.
    Pernomian L; Duarte-Silva M; de Barros Cardoso CR
    Clin Rev Allergy Immunol; 2020 Dec; 59(3):382-390. PubMed ID: 32279195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indoles: metabolites produced by intestinal bacteria capable of controlling liver disease manifestation.
    Hendrikx T; Schnabl B
    J Intern Med; 2019 Jul; 286(1):32-40. PubMed ID: 30873652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lychee (Litchi chinensis Sonn.) Pulp Phenolic Extract Provides Protection against Alcoholic Liver Injury in Mice by Alleviating Intestinal Microbiota Dysbiosis, Intestinal Barrier Dysfunction, and Liver Inflammation.
    Xiao J; Zhang R; Zhou Q; Liu L; Huang F; Deng Y; Ma Y; Wei Z; Tang X; Zhang M
    J Agric Food Chem; 2017 Nov; 65(44):9675-9684. PubMed ID: 29041775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibiotic-induced dysbiosis alters host-bacterial interactions and leads to colonic sensory and motor changes in mice.
    Aguilera M; Cerdà-Cuéllar M; Martínez V
    Gut Microbes; 2015; 6(1):10-23. PubMed ID: 25531553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of intestinal bacteria with fatty liver diseases and cirrhosis.
    Guohong-Liu ; Qingxi-Zhao ; Hongyun-Wei
    Ann Hepatol; 2019; 18(6):796-803. PubMed ID: 31558417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammation in alcohol-associated liver disease progression.
    Lotersztajn S; Riva A; Wang S; Dooley S; Chokshi S; Gao B
    Z Gastroenterol; 2022 Jan; 60(1):58-66. PubMed ID: 35042254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Perspective Of Intestinal Immune-Microbiome Interactions In Alcohol-Associated Liver Disease.
    Bruellman R; Llorente C
    Int J Biol Sci; 2021; 17(1):307-327. PubMed ID: 33390852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.